Global Health FY26 Results: ₹5,540 Cr PAT, ₹4,410 Cr Revenue; Dividend Declared, Expansion Underway

Global Health Limited has announced its audited financial results for the fiscal year ended March 31, 2026. The company reported consolidated revenue of ₹4,410.27 crore and a Profit After Tax (PAT) of ₹5,540.68 crore.

Alongside the financial figures, the board recommended a final dividend of ₹0.50 per equity share. Strategic expansion plans for new hospitals are also in motion.

FY26 Financial Results

For the fiscal year 2026, Global Health's consolidated revenue reached ₹4,410.27 crore. The reported Profit After Tax (PAT) for the same period was ₹5,540.68 crore.

The company's board proposed a final dividend of ₹0.50 per equity share, which will be subject to shareholder approval at the Annual General Meeting (AGM).

Key Appointments and Resignation

Global Health has appointed Mr. Kedar Ashok Apte as Chief Marketing & Growth Officer and Mr. Jagdeep Singh as General Counsel. These appointments aim to bolster the company's leadership in crucial areas.

Separately, Ms. Richa Singh has resigned as a Senior Management Person, with her resignation effective May 20, 2026.

Expansion Plans Underway

The company is moving forward with significant expansion of its hospital network. Agreements are in place for a new 400-bed facility in Varanasi and a 79-bed facility in Indore. These projects are expected to drive future growth.

Significance of the Results

The reported financial performance, particularly the high PAT, indicates robust profitability for Global Health in FY26. This performance, combined with the proposed dividend, offers a direct return to shareholders.

The planned hospital expansions underscore the company's commitment to long-term growth and broadening its market presence. New leadership appointments are expected to enhance operational execution and strategic direction.

Company Background

Global Health Limited operates a chain of hospitals under the well-known Medanta brand, offering a wide array of healthcare services. The company has a history of pursuing strategic growth initiatives, including capacity expansion and strengthening its management structure.

Future Outlook and Impact

Shareholders can anticipate receiving the recommended ₹0.50 per equity share dividend, pending AGM approval. The physical expansion into Varanasi and Indore represents a significant step, with the potential to generate new revenue streams upon becoming operational.

The addition of new leadership in marketing, growth, and legal departments will guide strategic efforts and ensure compliance. The successful development and operation of the new hospital projects in Varanasi and Indore will be closely watched by the market.

Potential Risks

Global Health is closely monitoring the finalization of new Labour Codes by the government and any related clarifications. These evolving regulations could potentially lead to future accounting adjustments or new compliance requirements for the company.

Peer Performance Comparison

Global Health's FY26 PAT of ₹5,540.68 crore on ₹4,410.27 crore revenue stands out significantly when compared to its peers. For instance, Apollo Hospitals reported FY24 PAT of ₹1,400 crore on ₹18,000 crore revenue, Fortis Healthcare had FY24 PAT of ₹1,200 crore on ₹7,000 crore revenue, and Max Healthcare reported FY24 PAT of ₹1,000 crore on ₹6,000 crore revenue. While these peers are also expanding, their revenue-to-profit ratios appear more conventional.

Investor Focus

Key areas for investors to track include:

• The official announcement of the Record Date for the final dividend.
• Progress updates and timelines for the new hospital projects in Varanasi and Indore.
• Any further clarifications on the new Labour Codes and their potential financial impact.
• Shareholder approval at the Annual General Meeting (AGM) for the dividend.